Nora Feldman
Supplements Reviewer
Supplement shoppers asking "does this actually work?"
Nora Feldman reviews supplements and compounds against the evidence — creatine, magnesium, NMN, the lot — assigning honest strength-of-evidence ratings and cheerfully puncturing the hype that surrounds them.
Latest articles
Beyond LDL: The New Lipid Targets Reshaping Cardiovascular Risk
Human genetics is guiding a fresh class of lipid drugs — Lp(a) inhibitors and lipoprotein-lipase activators — aimed at the residual heart risk statins can't reach.
Beating Rebound Headaches: What the Network Meta-Analysis Says Actually Works
A 2025 network meta-analysis ranks withdrawal and bridging strategies for medication-overuse headache. The combinations win — but the evidence is moderate, not magical.
GLP-1 Drugs and Alcohol: A Small Trial Hints at a Delayed Drinking Effect
A secondary analysis of a placebo-controlled trial in patients with alcohol use disorder and obesity found exenatide lowered a blood marker of drinking — but only after months, not weeks.
Ergothioneine: The Mushroom Thiol Quietly Climbing the Healthspan Charts
A single mechanism paper gives a long-suspected 'longevity vitamin' its first credible story — in worms and aged rats. Humans are not worms.
Centenarian Blood: Why the Longest-Lived Humans Carry Youth-Like Red Cells and Acetyl Marks
Two 2025 studies converge on measurable biological signatures that set centenarians—and long-lived mammals—apart. The evidence is intriguing, the mechanisms partial, the hype unwarranted.